GANX Gain Therapeutics, Inc.

Fundamentals / CIK 0001819411 / USD

Gain Therapeutics, Inc. reported $13.23M in total assets and a net loss of $17.98M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GANX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$2.51M$1.26M$0-$20.83MFY 2020 Revenue: $29KFY 2020 Net Income: -$3.58M2020FY 2021 Revenue: $165KFY 2021 Net Income: -$13.89M2021FY 2022 Revenue: $140KFY 2022 Net Income: -$17.59M2022FY 2023 Revenue: $55KFY 2023 Net Income: -$22.27M2023FY 2024 Net Income: -$20.41M2024FY 2025 Net Income: -$20.16M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- $55K $140K $165K $29K
Research & Development $10.21M $10.79M $11.52M $8.38M $7.16M $2.26M
Total Operating Expenses $18.71M $20.35M $22.31M $17.92M $13.99M $3.51M
Operating Income -$18.71M -$20.35M -$22.25M -$17.78M -$13.83M -$3.48M
EBITDA -$18.62M -$20.27M -$22.17M -$17.71M -$13.81M -$3.47M
Interest Expense -- -- -- -- $0 --
Income Before Tax -$19.30M -$19.87M -$22.19M -$17.50M -$13.89M -$3.57M
Income Tax Expense $861K $537K $79K $93K $4.0K $5.4K
Net Income -$20.16M -$20.41M -$22.27M -$17.59M -$13.89M -$3.58M
Basic EPS -$0.61 -$0.89 -$1.71 -$1.48 -$1.37 -$1.33
Diluted EPS -$0.61 -$0.89 -$1.71 -$1.48 -$1.37 -$1.33
Basic Shares Outstanding 33.0M 22.9M 13.0M 11.9M 10.2M 2.7M
Diluted Shares Outstanding 33.0M 22.9M 13.0M 11.9M 10.2M 2.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.42M $2.14M $2.76M $2.35M $2.85M $2.76M $2.26M $1.22M
Total Operating Expenses $3.20M $4.68M $5.35M $4.47M $4.79M $5.09M $4.37M $3.33M
Operating Income -$3.20M -$4.68M -$5.35M -$4.47M -$4.79M -$5.09M -$4.37M -$3.33M
EBITDA -$3.18M -$4.65M -$5.33M -$4.44M -$4.76M -$5.07M -$4.35M -$3.31M
Income Before Tax -$3.09M -$4.57M -$5.43M -$4.47M -$4.74M -$5.67M -$4.43M -$3.26M
Income Tax Expense $72K $104K $183K $70K $549K $141K $101K $505K
Net Income -$3.16M -$4.68M -$5.61M -$4.54M -$5.28M -$5.81M -$4.53M -$3.77M
Basic EPS -$0.07 -$0.11 -$0.13 -- -$0.15 -$0.19 -$0.16 --
Diluted EPS -$0.07 -$0.11 -$0.13 -- -$0.15 -$0.19 -$0.16 --
Basic Shares Outstanding 43.8M 42.9M 42.2M -- 35.0M 30.3M 28.7M --
Diluted Shares Outstanding 43.8M 42.9M 42.2M -- 35.0M 30.3M 28.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $20.84M $10.39M $11.79M $7.31M $36.88M $7.49M
Short-Term Investments -- -- $5.00M $12.83M -- --
Cash & Short-Term Investments $20.84M $10.39M $16.80M $20.14M $36.88M $7.49M
Accounts Receivable, Net -- -- -- -- -- $8.5K
Total Current Assets $22.24M $11.60M $17.78M $21.09M $37.72M $8.99M
Property, Plant & Equipment, Net $75K $104K $126K $144K $106K $30K
Intangible Assets $103K -- -- -- -- --
Long-Term Investments -- -- -- $1.94M -- --
Other Non-Current Assets -- -- -- -- -- $52K
Total Non-Current Assets $582K $521K $830K $3.01M $1.26M $617K
Total Assets $22.82M $12.12M $18.61M $24.10M $38.99M $9.60M
Accounts Payable $825K $946K $1.32M $1.63M $560K $962K
Short-Term Debt $101K $110K $119K $108K $104K $23K
Other Current Liabilities $2.31M $2.44M $2.16M $2.11M $1.40M $768K
Total Current Liabilities $3.35M $3.91M $4.95M $4.13M $2.55M $2.11M
Long-Term Debt $300K $328K $449K $495K $590K $716K
Total Non-Current Liabilities $902K $873K $1.08M $1.09M $1.61M $1.29M
Total Liabilities $4.25M $4.78M $6.03M $5.22M $4.17M $3.40M
Total Debt (incl. Leases) $732K $653K $1.03M $1.27M $1.61M $1.26M
Common Stock $4.2K $2.7K $1.6K $1.2K $1.2K $354
Retained Earnings -$101.4M -$60.78M -$38.52M -$20.93M -$7.03M -$3.46M
Accumulated Other Comp. Income $777K -$248K $247K $36K -$91K -$153K
Total Stockholders' Equity $18.56M $7.34M $12.58M $18.88M $34.82M $6.20M
Total Equity $18.56M $7.34M $12.58M $18.88M $34.82M $6.20M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $11.70M $13.08M $16.54M $20.84M $8.81M $6.69M $9.07M $10.39M
Cash & Short-Term Investments $11.70M $13.08M $16.54M $20.84M $8.81M $6.69M $9.07M $10.39M
Total Current Assets $12.70M $14.97M $18.22M $22.24M $10.52M $9.31M $11.15M $11.60M
Property, Plant & Equipment, Net $40K $47K $54K $75K $86K $96K $98K $104K
Intangible Assets $66K -- -- $103K -- -- -- --
Total Non-Current Assets $534K $452K $517K $582K $454K $527K $473K $521K
Total Assets $13.23M $15.42M $18.74M $22.82M $10.97M $9.83M $11.62M $12.12M
Accounts Payable $603K $1.22M $1.52M $825K $1.58M $2.71M $2.15M $946K
Short-Term Debt $120K $124K $100K $101K $126K $126K $113K $110K
Other Current Liabilities $1.49M $1.98M $2.15M $2.31M $2.34M $2.20M $2.40M $2.44M
Total Current Liabilities $2.37M $3.43M $3.89M $3.35M $4.17M $5.20M $5.03M $3.91M
Long-Term Debt $189K $220K $273K $300K $299K $325K $314K $328K
Total Non-Current Liabilities $712K $696K $845K $902K $892K $941K $816K $873K
Total Liabilities $3.08M $4.13M $4.73M $4.25M $5.06M $6.14M $5.84M $4.78M
Total Debt (incl. Leases) $677K $610K $672K $732K $605K $681K $607K $653K
Common Stock $4.4K $4.3K $4.2K $4.2K $3.6K $3.1K $2.9K $2.7K
Retained Earnings -$114.8M -$111.6M -$101.4M -$101.4M -$81.19M -$81.19M -$81.19M -$60.78M
Accumulated Other Comp. Income $873K $1.00M $997K $777K $563K $584K -$120K -$248K
Total Stockholders' Equity $10.15M $11.29M $14.01M $18.56M $5.91M $3.70M $5.78M $7.34M
Total Equity $10.15M $11.29M $14.01M $18.56M $5.91M $3.70M $5.78M $7.34M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$20.16M -$20.41M -$22.27M -$17.59M -$13.89M -$3.58M
Depreciation & Amortization $94K $84K $84K $64K $15K $9.6K
Stock-Based Compensation $1.80M $2.39M $3.26M $1.53M $839K $82K
Change in Working Capital -$1.01M -$1.08M $442K $1.51M -$330K --
Change in Receivables -- -- -- -- $8.3K -$196
Change in Payables -- -- -$643K $1.07M -$521K $396K
Operating Cash Flow -$18.47M -$18.87M -$18.87M -$14.69M -$12.37M -$3.24M
Capital Expenditure -- -$22K -$15K -$119K -$94K -$21K
Free Cash Flow -- -$18.90M -$18.88M -$14.81M -$12.46M -$3.26M
Purchases of Investments -- -- -$1.96M -$17.74M -- --
Investing Cash Flow -- $4.98M $10.22M -$14.77M -$94K -$21K
Financing Cash Flow $28.45M $13.01M $12.64M -$79K $41.77M $10.49M
Net Change in Cash $10.46M -$1.41M $4.49M -$29.57M $29.41M $7.19M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.16M -$4.68M -$5.61M -$4.54M -$5.28M -$5.81M -$4.53M -$3.77M
Depreciation & Amortization $19K $27K $21K $28K $23K $22K $21K $21K
Stock-Based Compensation $376K $566K $404K $402K $460K $522K $420K $359K
Change in Working Capital -$224K -$698K $226K -$522K -$136K -$508K $159K -$621K
Operating Cash Flow -$3.05M -$4.68M -$4.73M -$4.62M -$4.93M -$5.10M -$3.82M -$3.45M
Investing Cash Flow -- -- -- -- -- -- -- -$43K
Financing Cash Flow $1.75M $1.37M $404K $16.55M $7.03M $2.47M $2.40M $2.31M
Net Change in Cash -$1.39M -$3.46M -$4.30M $12.03M $2.11M -$2.37M -$1.31M -$1.67M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -40328.3% -12688.1% -8379.8% -12047.5%
Net Profit Margin -- -- -40354.3% -12555.1% -8418.9% -12387.7%
Return on Equity (ROE) -108.6% -278.1% -177.0% -93.2% -39.9% -57.7%
Return on Assets (ROA) -88.4% -168.4% -119.7% -73.0% -35.6% -37.3%
Current Ratio 6.63x 2.97x 3.59x 5.11x 14.78x 4.25x
Quick Ratio 6.22x 2.66x 3.39x 4.88x 14.45x 3.55x
Debt to Equity 0.04x 0.09x 0.08x 0.07x 0.05x 0.20x
Revenue Growth (YoY) -- -- -60.6% -15.1% +471.3% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -177.2% -178.1% -151.6% -108.6% -328.1% -503.1% -362.1% -278.1%
Return on Assets (ROA) -135.9% -130.4% -113.3% -88.4% -176.7% -189.1% -180.0% -168.4%
Current Ratio 5.36x 4.36x 4.69x 6.63x 2.52x 1.79x 2.22x 2.97x
Quick Ratio 4.94x 3.81x 4.26x 6.22x 2.11x 1.29x 1.80x 2.66x
Debt to Equity 0.07x 0.05x 0.05x 0.04x 0.10x 0.18x 0.10x 0.09x
Source: SEC EDGAR CompanyFacts (CIK 0001819411) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal